Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03504514
Other study ID # 2017-A00109-44
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 6, 2019
Est. completion date September 2020

Study information

Verified date August 2019
Source Centre d'Investigation Clinique et Technologique 805
Contact Hélène Prigent, MD PhD
Phone 0033147107911
Email helene.prigent@aphp.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Ventilation is a major treatment of respiratory failure due to neuromuscular disorders. First line treatment is noninvasive ventilation (NIV) but in some situations, especially in case of NIV inefficiency, invasive ventilation with tracheostomy (IVT) may be required. In both situations, patients may become dependent on ventilatory support with the disease evolution. Ventilation then can interfere speech and the quality of communication of the patients. Modification of the ventilation parameters may result in improved speech quality (for example, positive expiratory pressure (PEP) while not necessary for ventilation quality can dramatically improve speech in tracheostomized patients). Therefore, it would be of interest to allow patients to benefit from these specific parameters when they need to speak without maintaining them when patients are not speaking. We want to evaluate a specific ventilator feature which can detect speech and switch to specific ventilation parameters adapted for speech We believe that this feature will improve significantly speech quality in patients dependant either on NIV or IVT.


Description:

Nowadays, the first line treatment of chronic respiratory failure in neuromuscular disorder is non invasive ventilation (NIV). However, while NIV can compensate the respiratory disability and significantly delays significantly the necessity for invasive ventilation with a tracheostomy (IVT), it is used for significant periods of time during daytime in patients with severe respiratory failure and can therefore interfere with patients' speech. Moreover, if NIV becomes inefficient, IVT may be required to pursue ventilatory support to treat the respiratory failure; tracheostomy also interferes with phonation and specific adaptations are necessary to optimize phonation and speech quality.

Adaptation of ventilation parameters (mainly triggering sensitivity and use of positive expiratory pressure (PEP)) can significantly improve speech quality and therefore ventilated patients' communication. These adapted parameters are not strictly necessary for ventilation outside of speaking periods. It would be of interest to be able to use them exclusively during speech. In neuromuscular patients, the major motor disability constitutes a challenge as most patients are unable to use themselves the controls of their ventilator (and to potentially switch to a speech adapted ventilation program). We want to evaluate a device able to automatically detect speech and to transitorily switch from the patient's usual ventilation parameters to speech specific parameters set to optimize phonation quality.

Specific adaptations differs between NIV or IVT, therefore we will evaluation two groups of ventilation dependent patients divided according to their ventilation mode.

We believe that this device may improve the speech of NIV patients as well as IVT patients. Patients would benefit from an appropriate ventilator support without any ventilation desynchronization during speech. Speech would be more fluent and natural which would result in improved communication.

Objectives The main objective of this study is to demonstrate that phonation is improved by the use of a device allowing the transitory switch to specific speech parameters of ventilation in neuromuscular ventilator dependent patient whether during NIV or during IMT.


Recruitment information / eligibility

Status Recruiting
Enrollment 28
Est. completion date September 2020
Est. primary completion date September 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- adult patients (age > or equal to 18)

- Neuromuscular patients with a restrictive respiratory failure without major bulbar involvement.

- Adult patient.

- Ventilator dependancy= ventilation duration of 16h/day or more either with NIV or IMT

- Leak ventilation for IMT patients

- Respiratory autonomy of at leat 1h per day

- Usual ventilation mode : assist control mode (either pressure or volume controlled mode) ou spontaneous breathing mode with target volume

- Stable hemodynamic state

- Signed informed consent

Exclusion Criteria:

- Refusal to participate

- Use of cuffed tracheostomy tube

- Inability to read

- Pregnancy

- Protected adults

- Acute respiratory failure

- Hemodynamic instability

- not registered with the social security system

Study Design


Related Conditions & MeSH terms


Intervention

Device:
speech trials during different ventilation conditions
ventilator parameters are modified
Other:
speech trial
reading duration, vocal flow, intelligibility and voice quality will be evaluated during speech

Locations

Country Name City State
France Raymond Poincaré hospital Garches

Sponsors (1)

Lead Sponsor Collaborator
Centre d'Investigation Clinique et Technologique 805

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary reading duration duration for reading a specific text in seconds 15 minutes
Secondary Vocal flow vocal flow in syllables/second during the reading of a specific text 15 minutes
Secondary vocal range vocal range from lowest to highest pitch 2 minutes
Secondary intelligibility evaluation of intelligibility during reading evaluated by listeners blinded to ventilation conditions 15 minutes
Secondary Speech quality evaluation of prosodia by listeners blinded to ventilation conditions 5 min
Secondary Speech quality evaluation of speech quality by the patient using a visual analogical scale 1 minute
Secondary Speech comfort evaluation of speech comfort by the patient using a visual analogical scale 1 minute
Secondary Respiratory comfort evaluation of respiratory comfort by the patient using a visual analogical scale 1 minute
Secondary dyspnea evaluation of dyspnea during speech evaluated with the modified Borg scale (ranking from 0 to10) 1 minute
Secondary oxygen saturation evaluation of Respiratory tolerance during speech by measuring oxygen saturation 15 min
Secondary respiratory rate evaluation of Respiratory tolerance during speech by measuring respiratory rate 15 min
Secondary cardiac frequency evaluation of Cardiovascular tolerance during speech by measuring cardiac frequency 15 min
Secondary Patient satisfaction evaluation of Patient satisfaction with speech with the ventilation mode by the patient using a visual analogical scale 1 minute
See also
  Status Clinical Trial Phase
Completed NCT05921656 - Construction and Evaluation of Airway Leakage Risk Model of Patients With Endotracheal Tube
Recruiting NCT03941002 - Continuous Evaluation of Diaphragm Function N/A
Withdrawn NCT04288076 - The Brain and Lung Interaction (BALI) Study N/A
Completed NCT03031860 - Semi-quantitative Cough Strength Score (SCSS) N/A
Completed NCT02545621 - A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study
Completed NCT02312869 - Local Assessment of Management of Burn Patients N/A
Completed NCT01885442 - TryCYCLE: A Pilot Study of Early In-bed Leg Cycle Ergometry in Mechanically Ventilated Patients N/A
Completed NCT01204281 - Proportional Assist Ventilation (PAV) in Early Stage of Critically Ill Patients Phase 4
Terminated NCT01059929 - Dexmedetomidine Versus Propofol in the Medical Intensive Care Unit (MICU) Phase 4
Completed NCT00824239 - Intermittent Sedation Versus Daily Interruption of Sedation in Mechanically Ventilated Patients Phase 3
Completed NCT00529347 - Mechanical Ventilation Controlled by the Electrical Activity of the Patient's Diaphragm - Effects of Changes in Ventilator Parameters on Breathing Pattern Phase 1
Unknown status NCT00260676 - Protective Ventilatory Strategy in Potential Organ Donors Phase 3
Terminated NCT00205517 - Sedation and Psychopharmacology in Critical Care N/A
Completed NCT03281785 - Ultrasound of Diaphragmatic Musculature in Mechanically Ventilated Patients. N/A
Recruiting NCT04110613 - RCT: Early Feeding After PEG Placement N/A
Completed NCT04410783 - The Emergency Department Sedation Pilot Trial N/A
Recruiting NCT04821453 - NAVA vs. CMV Crossover in Severe BPD N/A
Completed NCT03930147 - Ventilation With ASV Mode in Children N/A
Recruiting NCT05029167 - REstrictive Versus LIberal Oxygen Strategy and Its Effect on Pulmonary Hypertension After Out-of-hospital Cardiac Arrest (RELIEPH-study) N/A
Recruiting NCT04849039 - Lung Microbiota and VAP Development (PULMIVAP)